Mirae Asset Global Etfs Holdings Ltd. Acrivon Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 6,508 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,508Holding current value
$0% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ACRV
# of Institutions
57Shares Held
23.7MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA8.34MShares$00.0% of portfolio
-
Perceptive Advisors LLC New York, NY5.36MShares$00.0% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA2.12MShares$00.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.12MShares$00.0% of portfolio
-
Marshall Wace, LLP London, X0949KShares$00.0% of portfolio